Meet Investors and Pharmaceutical Companies: Business Development Conference in Munich
High-ranking speakers from the European biotech sector as well as internationally active pharmaceutical companies and investors have already registered for the third European Business Development Conference, which will be hosted by BIO Deutschland and EBE (Emerging Biopharmaceutical Enterprises) on 24 and 25 June in Munich.
This year’s conference, which is being generously sponsored by BioM Biotech Cluster Development GmbH and the Bavarian State Government as platinum sponsors, by Merck Serono as a gold sponsor, and by Boehringer Ingelheim as a silver sponsor, will focus on the topics, "Partnering for proof of concept or develop it yourself and sell late (or never)?", "Too small to be seen by the industry giants? How Europe’s biotech companies can attract more attention." and "Are niche markets the guarantee for future success? The case of therapies for rare diseases."
Confirmed speakers include representatives from the following companies: Ablynx, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, MediGene, Merck Serono, PharmaMar, sanofi-aventis, Sofinnova Partners and Wilex.
Further information is available at